locoregional control

Related by string. * : locoregional recurrence . locoregional . locoregional disease / controls . Controls . CONTROL . controled . controling . CONTROLS . con trol . controler . Con trol : Disease Control . Pollution Control Board . CONTROL IN PROCURING COMPILING . Animal Control . Johnson Controls . control . Traffic Control . Pennsylvania Liquor Control . Minnesota Pollution Control * *

Related by context. Frequent words. (Click for all words.) 60 plus prednisone 60 Secondary endpoints included 59 free survival PFS 59 FOLFIRI 58 median PFS 57 Secondary endpoints include 56 cytogenetic response 56 bone metastasis 55 axitinib 55 infarct size 54 annualized relapse 54 distant metastases 54 zoledronic acid 54 chemoradiation 54 FOLFOX 54 temsirolimus 54 P = .# 53 LVEF 53 Secondary endpoints 53 metastatic renal cell carcinoma 53 neoadjuvant chemotherapy 52 mitoxantrone 52 RECIST criteria 52 decitabine 52 cardiac dysfunction 52 etoposide 52 neoadjuvant 51 Median survival 51 sustained virologic response 51 histologic 51 adjuvant therapy 51 topotecan 51 mg kg dose 51 p = #.# [004] 51 evaluable 51 liver metastases 51 reoperation 51 coronary revascularization 50 HRPC 50 tesmilifene 50 bortezomib 50 Postoperative 50 tumor shrinkage 50 prognostic factor 50 gemcitabine 49 VIDAZA 49 RECIST 49 carboplatin 49 tumor recurrence 49 imatinib 49 tumor regression 49 adjuvant chemotherapy 48 GvHD 48 Recurrence 48 TNFerade 48 GVAX 48 pg mL 48 % CI #.#-#.# [006] 48 target lesion revascularization 47 pemetrexed 47 gefitinib 47 limb salvage 47 estrogen receptor negative 46 erlotinib 46 poorer prognosis 46 palliation 46 virologic failure 46 CD4 + cell 46 radical prostatectomy 45 p = #.# [002] 45 survival 45 CI = 45 cisplatin 45 reperfusion 45 EGFR inhibitors 45 morbidity mortality 45 IPSS 45 patency 44 breast cancer recurrence 44 postmenopausal breast cancer 44 Vectibix 44 surgical resection 44 mammary tumors 44 glomerular filtration rate 44 abiraterone 44 patients undergoing chemotherapy 44 Hospitalizations 44 untreated mice 44 revascularization 44 ipilimumab 43 renal transplantation 43 tumor progression 42 recurrence 42 prostate tumor 42 Main Outcome Measures 42 prognostic factors 42 non Hodgkin Lymphoma 41 kidney transplant recipients 41 n = 41 cells/mm3 41 ±

Back to home page